Purple Biotech (PPBT) Securities Borrowed (2024 - 2026)
Purple Biotech's (PPBT) quarterly Securities Borrowed came in at -$2.2 million in Q1 2026, down 133.4% year-on-year from $6.5 million in Q1 2025, and down 116.22% on a QoQ basis from -$1.0 million in Q2 2025.
Purple Biotech (PPBT) Securities Borrowed (2024 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 3 years of Securities Borrowed data on file, last reported at -$2.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.17 Mn |
| Jun 30, 2025 | -1.01 Mn |
| Mar 31, 2025 | -931,000.00 |
| Jun 30, 2024 | -1.42 Mn |
| Mar 31, 2024 | -607,000.00 |